Arrowstreet Capital
MYOV

Arrowstreet Capital’s Myovant Sciences Ltd. MYOV Stock Holding History

Arrowstreet Capital’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-69,800
Closed -$1.59M – 1952
2021
Q2 		$1.59M Buy
+69,800
New +$1.47M ﹤0.01% 1412

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital's MYOV Position: Q3 2021 in Review

Arrowstreet Capital sold out of Myovant Sciences Ltd. (MYOV) in Q3 2021, closing a stake of 69,800 shares — an estimated $1.59M sold.

Arrowstreet Capital first reported a position in MYOV in Q2 2021 and held it in 1 quarter. The position peaked at $1.59M in Q2 2021. 105 funds tracked by Wall St. Rank hold MYOV as of Q3 2021.

  • Arrowstreet Capital reported no remaining Myovant Sciences Ltd. position as of Q3 2021 after selling out during the quarter.
  • Arrowstreet Capital sold 69,800 Myovant Sciences Ltd. shares in Q3 2021, an estimated $1.59M.
  • Arrowstreet Capital first reported a position in Myovant Sciences Ltd. in Q2 2021 and held it in 1 quarter.
  • Arrowstreet Capital's Myovant Sciences Ltd. position peaked at $1.59M in Q2 2021.
  • 105 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2021.

Based on Arrowstreet Capital's 13F filing for Q3 2021, filed 12 Nov 2021.